Ms. Archana Sonkar - Cancer - Women Researcher Award 🏆
Babasaheb Bhimrao Ambedkar university, Lucknow - India
Professional Profiles
Early Academic Pursuits
She began her academic journey by completing her High School and Intermediate education from the UP Board in 2008 and 2011, respectively. She pursued a D. Pharm. from B.T.E, followed by a B. Pharm. from UPTU, graduating in 2016. She furthered her academic pursuits with an M.Pharm. at BBAU, spanning from 2016 to 2018. Currently, she is engaged in a Ph.D. in Pharmacology at BBAU, demonstrating a relentless pursuit of excellence in pharmaceutical sciences.
Professional Endeavors
She has accrued a wealth of experience in the pharmaceutical domain. Her professional journey boasts teaching experience of one year and a robust research tenure of five years, focusing extensively on pharmacology, cancer, antioxidants, and cell lines.
Contributions and Research Focus in Cancer
Her research endeavors have been prolific, marked by multiple publications in esteemed journals. Notable among these is her work on "Pentapeptide cRGDfK-Surface Engineered Nanostructured Lipid Carriers as an Efficient Tool for Targeted Delivery of Tyrosine Kinase Inhibitor for Battling Hepatocellular Carcinoma" published in the International Journal of Nanomedicine.
Accolades and Recognition
Her academic prowess is underscored by her achievements. She secured commendable ranks in the Graduate Pharmacy Aptitude Test (GPAT) in both 2016 (AIR-1295) and 2018, showcasing her acumen and dedication in the field of pharmacy.
Impact and Influence
Her contribution to the scientific community extends beyond academia. She has contributed articles on pressing issues like the impact of COVID-19 on migrant workers in India, showcasing her commitment to social issues and their implications.
Legacy and Future Contributions
With a rich academic foundation, extensive research experience, a trail of scholarly publications, and active participation in scientific discourse, Her trajectory is poised toward leaving an indelible mark in the pharmaceutical landscape. Her commitment to advancing pharmacological research and her interdisciplinary approach towards addressing healthcare, Cancer challenges positions her as a promising influencer and contributor to the future of pharmaceutical sciences.
Notable Publications
- A Comprehensive Review on PCSK9 as Mechanistic Target Approach in Cancer Therapy
- Ameliorative effect of fluvoxamine against colon carcinogenesis via COX-2 blockade with oxidative and metabolic stress reduction at the cellular, molecular and metabolic levels
- New Scope of Targeted Therapies in Lung Carcinoma
- Dextran-based nanomaterials in drug delivery applications